UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5) 5
life sciences & biomedicine (5) 5
science & technology (5) 5
female (4) 4
male (4) 4
rivaroxaban (4) 4
aged (3) 3
aged, 80 and over (3) 3
anticoagulants - therapeutic use (3) 3
dabigatran (3) 3
geriatrics & gerontology (3) 3
prevention (3) 3
venous thromboembolism - prevention & control (3) 3
anticoagulants (2) 2
anticoagulants - administration & dosage (2) 2
dosage and administration (2) 2
dvt (2) 2
hip and knee surgery (2) 2
internal medicine (2) 2
long-term care of the sick (2) 2
mechanical measures to prevent vte (2) 2
medical audit (2) 2
medical education (2) 2
practice guidelines as topic (2) 2
prevent venous thromboembolism events (2) 2
pulmonary embolism (2) 2
risk factors (2) 2
thromboembolism (2) 2
united states (2) 2
venous thromboembolism (2) 2
venous thromboembolism prophylaxis in ltc (2) 2
vte prophylaxis (2) 2
administration, oral (1) 1
analysis (1) 1
anticoagulants - adverse effects (1) 1
anticoagulation (1) 1
anticoagulation practice (1) 1
antithrombins - therapeutic use (1) 1
antithrombotic therapy (1) 1
arthroplasty, replacement, hip - adverse effects (1) 1
arthroplasty, replacement, knee - adverse effects (1) 1
atrial fibrillation (1) 1
atrial fibrillation - complications (1) 1
atrial fibrillation - drug therapy (1) 1
breast cancer (1) 1
breast cancer risk (1) 1
cardiac arrhythmia (1) 1
cardiovascular diseases (1) 1
chirurgie de la hanche et du genou (1) 1
clinical interventions in aging (1) 1
cocs ingestion during pregnancy - teratogenic, not been proven to be valid (1) 1
cocs ingestion during pregnancy – teratogenic, not been proven to be valid (1) 1
cocs, contraceptive patch and vaginal ring - containing ethinyl estradiol (1) 1
cocs, contraceptive patch and vaginal ring ‐ containing ethinyl estradiol (1) 1
combination ocs with nonandrogenic progestins - decreasing severity of acne (1) 1
combination ocs with nonandrogenic progestins ‐ decreasing severity of acne (1) 1
combination oral contraceptives - intrauterine device (1) 1
combination oral contraceptives ‐ intrauterine device (1) 1
contralateral breast cancer (1) 1
delirium (1) 1
delirium - classification (1) 1
delirium - epidemiology (1) 1
delirium - rehabilitation (1) 1
delirium is a common manifestation of acute brain dysfunction in critically ill patients with prevalence as high as 75%. in the last years there has been a progressive increase of publications regarding intensive care delirium, acknowledging its importance. the occurrence of delirium in icu is related to more adverse outcomes including self-extubation and removal of catheters, prolonged hospitalization, increased costs, higher mortality, and potentially, long-term cognitive impairment. the pathophysiology explaining the processes subtending the development of delirium is still elusive, though several theories have been discussed. it is known that different risk factors are associated with delirium in the icu. patients in icu frequently receive medications to treat pain and to ensure sedation, butan association between these drugs and delirium has been shown. therefore, this pharmacological exposure should be modified to reduce the risk factors. giving the multifactorial genesis of delirium, multicomponent interventions to prevent delirium developed in non-icu settings can be adapted to critically ill patients with the purpose of reducing the incidence. when delirium is diagnosed the use of typical and atypical antipsychotics may be effective for its treatment. future studies should evaluate target interventions to prevent delirium in the icu. (1) 1
disabled persons - psychology (1) 1
drug therapy (1) 1
endometrial cancer (1) 1
factor xa inhibitors (1) 1
factor xa inhibitors - administration & dosage (1) 1
general & internal medicine (1) 1
geriatrics (1) 1
health personnel - education (1) 1
health risk assessment (1) 1
heart-association (1) 1
homes for the aged (1) 1
incidence (1) 1
inservice training (1) 1
intensive care (1) 1
intensive care units - statistics & numerical data (1) 1
intervention (1) 1
life sciences (1) 1
long-term care facilities (1) 1
medicine and health sciences (1) 1
medicine, general & internal (1) 1
new anticoagulation therapy (1) 1
nursing homes (1) 1
obesity, independent risk factor - for venous thromboembolism (1) 1
obesity, independent risk factor ‐ for venous thromboembolism (1) 1
oral anticoagulants (1) 1
oral anticoagulants randomized controlled-trial (1) 1
ovulation, occurring soon after spontaneous or induced abortion (1) 1
patient compliance (1) 1
platelet aggregation inhibitors - administration & dosage (1) 1
platelet aggregation inhibitors - adverse effects (1) 1
platelet aggregation inhibitors - therapeutic use (1) 1
postoperative complications - prevention & control (1) 1
practice guidelines (1) 1
practice patterns, physicians (1) 1
predicting stroke (1) 1
prevalence (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of the American Medical Directors Association, ISSN 1525-8610, 2012, Volume 13, Issue 3, pp. 303 - 307
Journal Article
Le pharmacien hospitalier & clinicien, ISSN 2211-1042, 06/2012, Volume 47, Issue 2, pp. 132 - 138
.... Were taken into account: usual patient informations, clinical datas like factors increasing risk of veinous thromboembolism events (VTE... 
Hip and knee surgery | Rivaroxaban | Prevent venous thromboembolism events | Dabigatran
Journal Article
Journal Article
Le pharmacien hospitalier & clinicien, ISSN 2211-1042, 2012, Volume 47, Issue 3, pp. e1 - e7
Introduction: We conducted a Hospital drug utilization review (HDUR) of dabigatran and rivaroxaban in a French teaching hospital. This evaluation enhances the... 
Hip and knee surgery | Rivaroxaban | Prevent venous thromboembolism events | Dabigatran
Journal Article
06/2010, ISBN 9781405169165, 6
This chapter contains sections titled: Initiating oral contraceptive therapy Follow‐up Drug interactions Noncontraceptive health benefits Suggested reading 
combination OCs with nonandrogenic progestins ‐ decreasing severity of acne | women with history of gestational diabetes ‐ taking low‐dose OC formulations | steroid contraception, to prevent conception with first ovulation | combination oral contraceptives (COCs) ‐ intrauterine device (IUD) | synthetic sex steroids ‐ retarding biotransformation of drugs, phenazone and meperidine | obesity, independent risk factor ‐ for venous thromboembolism (VTE) | COCs, contraceptive patch and vaginal ring ‐ containing ethinyl estradiol | COCs ingestion during pregnancy – teratogenic, not been proven to be valid | ovulation, occurring soon after spontaneous or induced abortion | venous cardiovascular disease | COCs, contraceptive patch and vaginal ring - containing ethinyl estradiol | Steroid contraception, to prevent conception with first ovulation | COCs ingestion during pregnancy - teratogenic, not been proven to be valid | Women with history of gestational diabetes - taking low-dose OC formulations | Combination OCs with nonandrogenic progestins - decreasing severity of acne | Synthetic sex steroids - retarding biotransformation of drugs, phenazone and meperidine | Venous cardiovascular disease | Combination oral contraceptives (COCs) - intrauterine device (IUD) | Obesity, independent risk factor - for venous thromboembolism (VTE) | Ovulation, occurring soon after spontaneous or induced abortion
Book Chapter
International review of psychiatry (Abingdon, England), ISSN 1369-1627, 07/2009, Volume 21, Issue 1, pp. 43 - 58
Journal Article
10/2008, Cancer Treatment and Research, ISBN 9780387094625, Volume 147
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.